These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31794520)

  • 1. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
    AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
    Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
    PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
    Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
    PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV care coverage among HIV-positive adolescent girls and young women in South Africa: Results from the HERStory Study.
    Mathews C; Cheyip M; Beauclair R; Puren A; Lombard C; Jonas K; Ayalew KA; Govindasamy D; Kuo C; Dietrich J; Abdullah F; Gray G
    S Afr Med J; 2021 Apr; 111(5):460-468. PubMed ID: 34852889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.
    Voetsch AC; Duong YT; Stupp P; Saito S; McCracken S; Dobbs T; Winterhalter FS; Williams DB; Mengistu A; Mugurungi O; Chikwanda P; Musuka G; Ndongmo CB; Dlamini S; Nuwagaba-Biribonwoha H; Pasipamire M; Tegbaru B; Eshetu F; Biraro S; Ward J; Aibo D; Kabala A; Mgomella GS; Malewo O; Mushi J; Payne D; Mengistu Y; Asiimwe F; Shang JD; Dokubo EK; Eno LT; Zoung-Kanyi Bissek AC; Kingwara L; Junghae M; Kiiru JN; Mwesigwa RCN; Balachandra S; Lobognon R; Kampira E; Detorio M; Yufenyuy EL; Brown K; Patel HK; Parekh BS
    J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S73-S80. PubMed ID: 34166315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
    Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
    Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population-based survey, 2018.
    Abimiku A; Ramadhani HO; Moloney M; Stafford KA; Chang JC; Patel HK; Domaoal RA; Okoye M; Jelpe T; Bronson M; Ibrahim D; Swaminathan M; Gambo A; Charurat ME;
    HIV Med; 2023 Jul; 24(7):827-837. PubMed ID: 36945183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undisclosed HIV infection among MSM in a behavioral surveillance study.
    Hoots BE; Wejnert C; Martin A; Haaland R; Masciotra S; Sionean C; Smith A; Switzer WM; Paz-Bailey G;
    AIDS; 2019 Apr; 33(5):913-918. PubMed ID: 30649053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs.
    Fogel JM; Zhang Y; Palumbo PJ; Guo X; Clarke W; Breaud A; Richardson P; Piwowar-Manning E; Hamilton EL; Ha TV; Dumchev K; Djoerban Z; Hoffman I; Hanscom B; Miller WC; Eshleman SH
    AIDS Behav; 2019 Aug; 23(8):2101-2108. PubMed ID: 30600453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
    Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018).
    Jahun I; Ehoche A; Bamidele M; Yakubu A; Bronson M; Dalhatu I; Greby S; Agbakwuru C; Baffa I; Iwara E; Alagi M; Asaolu O; Mukhtar A; Ikpeazu A; Nzelu C; Tapdiyel J; Bassey O; Abimiku A; Patel H; Parekh B; Aliyu S; Aliyu G; Charurat M; Swaminathan M
    PLoS One; 2022; 17(8):e0273748. PubMed ID: 36037201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
    Grant-McAuley W; Fogel JM; Galai N; Clarke W; Breaud A; Marzinke MA; Mbwambo J; Likindikoki S; Aboud S; Donastorg Y; Perez M; Barrington C; Davis W; Kerrigan D; Eshleman SH
    PLoS One; 2020; 15(10):e0240890. PubMed ID: 33119663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
    Kim AA; Mukui I; Young PW; Mirjahangir J; Mwanyumba S; Wamicwe J; Bowen N; Wiesner L; Ng'ang'a L; De Cock KM;
    AIDS; 2016 Nov; 30(17):2685-2695. PubMed ID: 27782965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.